Magnani Giulia, Bricoli Serena, Ardissino Maddalena, Maglietta Giuseppe, Nelson Adam, Malagoli Tagliazucchi Guidantonio, Disisto Caterina, Celli Patrizia, Ferrario Maurizio, Canosi Umberto, Cernetti Carlo, Negri Francesco, Merlini Piera Angelica, Tubaro Marco, Berzuini Carlo, Manzalini Chiara, Ignone Gianfranco, Campana Carlo, Moschini Luigi, Ponte Elisabetta, Pozzi Roberto, Fetiveau Raffaela, Buratti Silvia, Paraboschi Elvezia, Asselta Rosanna, Botti Andrea, Tuttolomondo Domenico, Barocelli Federico, Biagi Andrea, Bonura Rosario, Moccetti Tiziano, Crocamo Antonio, Benatti Giorgio, Paoli Giorgia, Solinas Emilia, Notarangelo Maria Francesca, Moscarella Elisabetta, Calabrò Paolo, Duga Stefano, Niccoli Giampaolo, Ardissino Diego
Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Int J Cardiol. 2022 May 1;354:7-13. doi: 10.1016/j.ijcard.2022.02.015. Epub 2022 Feb 14.
Acute myocardial infarction with non-obstructive coronary artery disease (MINOCA) is frequent in patients experiencing an early-onset MI, but data concerning its long-term prognosis are limited and conflicting.
The Italian Genetic Study on Early-onset MI enrolled 2000 patients experiencing a first MI before the age of 45 years, and had a median follow-up of 19.9 years. The composite primary endpoint was cardiovascular (CV) death, non-fatal MI, and non-fatal stroke (MACE); the secondary endpoint was rehospitalisation for coronary revascularisation.
MINOCA occurred in 317 patients (15.9%) and, during the follow-up, there was no significant difference in MACE rates between them and the patients with obstructive coronary artery disease (MICAD: 27.8% vs 37.5%; adjusted hazard ratio [HR] 0.79, 95% confidence interval [CI] 0.57-1.09;p = 0.15). The CV death rate was lower in the MINOCA group (4.2% vs 8.4%, HR 0.26, 95%CI 0.08-0.86;p = 0.03), whereas the rates of non-fatal reinfarction (17.3% vs 25.4%; HR 0.76, 95%CI 0.52-1.13;p = 0.18), non-fatal ischemic stroke (9.5% vs 3.7%; HR 1.79, 95%CI 0.87-3.70;p = 0.12), and all-cause mortality (14.1% vs 20.7%, HR 0.73, 95%CI 0.43-1.25;p = 0.26) were not significantly different in the two groups. The rate of rehospitalisation for coronary revascularisation was lower among the MINOCA patients (6.7% vs 27.7%; HR 0.27, 95% CI 0.15-0.47;p < 0.001).
MINOCA is frequent and not benign in patients with early-onset MI. Although there is a lower likelihood of CV death,the long-term risk of MACE and overall mortality is not significantly different from that of MICAD patients.
非阻塞性冠状动脉疾病所致急性心肌梗死(MINOCA)在早发心肌梗死患者中很常见,但有关其长期预后的数据有限且相互矛盾。
意大利早发心肌梗死基因研究纳入了2000例45岁之前首次发生心肌梗死的患者,中位随访时间为19.9年。复合主要终点为心血管(CV)死亡、非致死性心肌梗死和非致死性卒中(MACE);次要终点为因冠状动脉血运重建再次住院。
317例患者(15.9%)发生MINOCA,随访期间,他们与阻塞性冠状动脉疾病患者(MICAD)的MACE发生率无显著差异(27.8%对37.5%;校正风险比[HR]0.79,95%置信区间[CI]0.57 - 1.09;p = 0.15)。MINOCA组的CV死亡率较低(4.2%对8.4%,HR 0.26,95%CI 0.08 - 0.86;p = 0.03),而两组间非致死性再梗死率(17.3%对25.4%;HR 0.76,95%CI 0.52 - 1.13;p = 0.18)、非致死性缺血性卒中率(9.5%对3.7%;HR 1.79,95%CI 0.87 - 3.70;p = 0.12)和全因死亡率(14.1%对20.7%,HR 0.73,95%CI 0.43 - 1.25;p = 0.26)无显著差异。MINOCA患者因冠状动脉血运重建再次住院的发生率较低(6.7%对27.7%;HR 0.27,95%CI 0.15 - 0.47;p < 0.001)。
MINOCA在早发心肌梗死患者中很常见且并非良性。虽然CV死亡可能性较低,但MACE和总体死亡率的长期风险与MICAD患者无显著差异。